Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced the closing of ...
A successful female entrepreneur with a strong charitable intent seeks to enhance her long-term impact on the causes she cares about. She possesses substantial private and public equities and has ...
LYON, France--(BUSINESS WIRE)--Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA Adocia (Euronext Paris : ...
PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (IPSC)-derived cell therapies for autoimmune diseases and cancer, today announced it has entered into a securities purchase ...
KALA BIO, Inc. announces $10.75 million private placement to advance clinical development of KPI-012 for severe eye diseases. KALA Bio, Inc., a clinical-stage biopharmaceutical company focused on ...